167 related articles for article (PubMed ID: 30827938)
1. Activation of BMP Signaling by FKBP12 Ligands Synergizes with Inhibition of CXCR4 to Accelerate Wound Healing.
Peiffer BJ; Qi L; Ahmadi AR; Wang Y; Guo Z; Peng H; Sun Z; Liu JO
Cell Chem Biol; 2019 May; 26(5):652-661.e4. PubMed ID: 30827938
[TBL] [Abstract][Full Text] [Related]
2. FKBP12 is a major regulator of ALK2 activity in multiple myeloma cells.
Quist-Løkken I; Andersson-Rusch C; Kastnes MH; Kolos JM; Jatzlau J; Hella H; Olsen OE; Sundan A; Knaus P; Hausch F; Holien T
Cell Commun Signal; 2023 Jan; 21(1):25. PubMed ID: 36717825
[TBL] [Abstract][Full Text] [Related]
3. BMPing Up Healing Capacity with FKBP12 Ligand.
Williams CH; Hong CC
Cell Chem Biol; 2019 May; 26(5):619-620. PubMed ID: 31100260
[TBL] [Abstract][Full Text] [Related]
4. CXCR4 antagonist delivery on decellularized skin scaffold facilitates impaired wound healing in diabetic mice by increasing expression of SDF-1 and enhancing migration of CXCR4-positive cells.
Liu H; Liu H; Deng X; Chen M; Han X; Yan W; Wang N
Wound Repair Regen; 2017 Aug; 25(4):652-664. PubMed ID: 28783870
[TBL] [Abstract][Full Text] [Related]
5. Leveraging Fungal and Human Calcineurin-Inhibitor Structures, Biophysical Data, and Dynamics To Design Selective and Nonimmunosuppressive FK506 Analogs.
Gobeil SM; Bobay BG; Juvvadi PR; Cole DC; Heitman J; Steinbach WJ; Venters RA; Spicer LD
mBio; 2021 Dec; 12(6):e0300021. PubMed ID: 34809463
[TBL] [Abstract][Full Text] [Related]
6. FKBP12 is the only FK506 binding protein mediating T-cell inhibition by the immunosuppressant FK506.
Xu X; Su B; Barndt RJ; Chen H; Xin H; Yan G; Chen L; Cheng D; Heitman J; Zhuang Y; Fleischer S; Shou W
Transplantation; 2002 Jun; 73(11):1835-8. PubMed ID: 12085010
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological mobilization of endogenous stem cells significantly promotes skin regeneration after full-thickness excision: the synergistic activity of AMD3100 and tacrolimus.
Lin Q; Wesson RN; Maeda H; Wang Y; Cui Z; Liu JO; Cameron AM; Gao B; Montgomery RA; Williams GM; Sun Z
J Invest Dermatol; 2014 Sep; 134(9):2458-2468. PubMed ID: 24682043
[TBL] [Abstract][Full Text] [Related]
8. FKBP12 dimerization mutations effect FK506 binding and differentially alter calcineurin inhibition in the human pathogen Aspergillus fumigatus.
Juvvadi PR; Bobay BG; Gobeil SMC; Cole DC; Venters RA; Heitman J; Spicer LD; Steinbach WJ
Biochem Biophys Res Commun; 2020 May; 526(1):48-54. PubMed ID: 32192767
[TBL] [Abstract][Full Text] [Related]
9. FKBP12-Dependent Inhibition of Calcineurin Mediates Immunosuppressive Antifungal Drug Action in
Ianiri G; Applen Clancey S; Lee SC; Heitman J
mBio; 2017 Oct; 8(5):. PubMed ID: 29066552
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus promotes hepatocellular carcinoma and enhances CXCR4/SDF‑1α expression in vivo.
Zhu H; Sun Q; Tan C; Xu M; Dai Z; Wang Z; Fan J; Zhou J
Mol Med Rep; 2014 Aug; 10(2):585-92. PubMed ID: 24912495
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of calcineurin inhibition by complexes of immunosuppressive drugs with human FK506 binding proteins.
Weiwad M; Edlich F; Kilka S; Erdmann F; Jarczowski F; Dorn M; Moutty MC; Fischer G
Biochemistry; 2006 Dec; 45(51):15776-84. PubMed ID: 17176100
[TBL] [Abstract][Full Text] [Related]
12. Major Improvement in Wound Healing Through Pharmacologic Mobilization of Stem Cells in Severely Diabetic Rats.
Qi L; Ahmadi AR; Huang J; Chen M; Pan B; Kuwabara H; Iwasaki K; Wang W; Wesson R; Cameron AM; Cui S; Burdick J; Sun Z
Diabetes; 2020 Apr; 69(4):699-712. PubMed ID: 31974141
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a cell model based on FKBP12 dimerization for screening of FK506-like neurotrophic small molecular compounds.
Xiao H; Wang LL; Shu CL; Yu M; Li S; Shen BF; Li Y
J Biomol Screen; 2006 Apr; 11(3):225-35. PubMed ID: 16490780
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of calcineurin-resistant derivatives of FK506 and selection of compensatory receptors.
Clemons PA; Gladstone BG; Seth A; Chao ED; Foley MA; Schreiber SL
Chem Biol; 2002 Jan; 9(1):49-61. PubMed ID: 11841938
[TBL] [Abstract][Full Text] [Related]
15. FK506 Induces Ligand-Independent Activation of the Bone Morphogenetic Protein Pathway and Osteogenesis.
Sangadala S; Devereaux EJ; Presciutti SM; Boden SD; Willet NJ
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30999619
[TBL] [Abstract][Full Text] [Related]
16. Reactivation of BMP signaling by suboptimal concentrations of MEK inhibitor and FK506 reduces organ-specific breast cancer metastasis.
Ren J; Wang Y; Ware T; Iaria J; Ten Dijke P; Zhu HJ
Cancer Lett; 2020 Nov; 493():41-54. PubMed ID: 32768522
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic screen identifies calcineurin-sparing FK506 analogs as BMP potentiators for treatment of acute kidney injury.
Larraufie MH; Gao X; Xia X; Devine PJ; Kallen J; Liu D; Michaud G; Harsch A; Savage N; Ding J; Tan K; Mihalic M; Roggo S; Canham SM; Bushell SM; Krastel P; Gao J; Izaac A; Altinoglu E; Lustenberger P; Salcius M; Harbinski F; Williams ET; Zeng L; Loureiro J; Cong F; Fryer CJ; Klickstein L; Tallarico JA; Jain RK; Rothman DM; Wang S
Cell Chem Biol; 2021 Sep; 28(9):1271-1282.e12. PubMed ID: 33894161
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the FKBP12-Encoding Genes in Aspergillus fumigatus.
Falloon K; Juvvadi PR; Richards AD; Vargas-Muñiz JM; Renshaw H; Steinbach WJ
PLoS One; 2015; 10(9):e0137869. PubMed ID: 26366742
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of osteogenic induction by FK506 via BMP/Smad pathways.
Kugimiya F; Yano F; Ohba S; Igawa K; Nakamura K; Kawaguchi H; Chung UI
Biochem Biophys Res Commun; 2005 Dec; 338(2):872-9. PubMed ID: 16246307
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective and antioxidant properties of FKBP-binding immunophilin ligands are independent on the FKBP12 pathway in human cells.
Tanaka K; Fujita N; Higashi Y; Ogawa N
Neurosci Lett; 2002 Sep; 330(2):147-50. PubMed ID: 12231433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
